Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Total revenue $ 5,447 $ 1,367 $ 12,455 $ 1,849
Operating expenses:        
Research and development 10,243 7,662 18,697 14,350
General and administrative 4,605 3,718 9,540 6,627
Total operating expenses 14,848 11,380 28,237 20,977
Loss from operations 9,401 10,013 15,782 19,128
Interest and other income, net 543 118 1,053 200
Interest and other expense, net (301) (98) (594) (393)
Change in fair value of warrant liabilities 6 298 2 912
Net loss attributable to common shareholders $ 9,153 $ 9,695 $ 15,321 $ 18,409
Net loss per share attributable to common shareholders:        
Basic and diluted $ 0.25 $ 0.36 $ 0.42 $ 0.68
Weighted average number of shares used in net loss per share calculations:        
Basic and diluted 36,819,846 27,062,440 36,779,638 27,026,263
Research And Development Revenue | Other        
Total revenue $ 0 $ 12 $ 0 $ 80
Research And Development Revenue | Related Party        
Total revenue 5,211 932 11,624 1,095
Grant        
Total revenue $ 236 $ 423 $ 831 $ 674